pancan.ai/Ask
what is known about trial:nct:NCT06625320
Understood asRecord NCT06625320View getStudy → table
Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) NCT06625320↗ Outcome: Ongoing
Computed from the knowledge API (getStudy); every record links to its source.